| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/29/2006 | EP0946715B1 Use of a modified protein c |
| 03/29/2006 | EP0852495B1 Pharmaceutical compositions containing hydroximic acid derivatives |
| 03/29/2006 | EP0751709B2 Use of bcl-2 for the manufacture of medicaments for the therapeutic treatment and prevention of diseases |
| 03/29/2006 | CN1753900A Inhibitors |
| 03/29/2006 | CN1753886A Process for producing acid adduct salt of polyacidic base compound |
| 03/29/2006 | CN1753885A Optically active dihydropyridine derivative |
| 03/29/2006 | CN1753694A Remedy for spinal injury containing interleukin-6 antagonist |
| 03/29/2006 | CN1752101A Protein separated from jellyfish and possessing antioxygenation activity and its application |
| 03/29/2006 | CN1752085A Aromatic hydrazide kind compound and its use in preparation of immune inhibitor |
| 03/29/2006 | CN1751692A Medicine Rb2 used for thrombolysis, anti reperfusion injury, improving microcirculation and repairing injured tissue and its prepn. method |
| 03/29/2006 | CN1751688A Wikipedia for application of altitude medicine |
| 03/29/2006 | CN1248514C Method and an arrangement for connecting and disconnecting communications links |
| 03/29/2006 | CN1247780C Mammalian sytokine-like polypeptide-10 |
| 03/29/2006 | CN1247613C Novel omega-conotoxin peptides |
| 03/29/2006 | CN1247605C Novel galactosylceramide analogs and beta-glucocerebrosidase activators, external skin preparations and method of activating beta-glucocerebrosidase using the analogs |
| 03/29/2006 | CN1247594C Bicyclic heteroaromatic compounds |
| 03/29/2006 | CN1247591C Indole derivative and its medicine application |
| 03/29/2006 | CN1247589C Tricyclic derivatives of indole with antiangiogenic activity |
| 03/29/2006 | CN1247588C Adenosine A2A receptor antagonists |
| 03/29/2006 | CN1247585C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives |
| 03/29/2006 | CN1247584C I-[alkyl] 1-[(heteroaryl) alkyl] and 1 [(aryl) alkyl] 7-pyridinyl-imidazo [1,2-a] pyrimidin-5(1h)-one derivatives |
| 03/29/2006 | CN1247577C Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 03/29/2006 | CN1247576C Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/29/2006 | CN1247575C Sulfamino ether substituted imidazoquinolines |
| 03/29/2006 | CN1247574C Isoindolin-1-one glucokinase activators |
| 03/29/2006 | CN1247568C Novel urea compounds as vanilloid receptor antagonist for treatment of pains |
| 03/29/2006 | CN1247567C 2-amino-3-(alkyl)-pyrimidone derivatives as GSKS beta. inhibitors |
| 03/29/2006 | CN1247553C 2-imino-1,3-thiazine derivs. |
| 03/29/2006 | CN1247547C Piperidine and piperazine substituted N-hydroxyformamides as inhibitors of metalloproteinases |
| 03/29/2006 | CN1247528C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 03/29/2006 | CN1247511C Tropolone derivative |
| 03/29/2006 | CN1247260C Analogs of parathyroid hormone |
| 03/29/2006 | CN1247258C Combination therapy using anti-angiogenic agents and TNF alpha |
| 03/29/2006 | CN1247256C Pharmaceutical combination for treatment of tissue damage owing to arterial irrigation defect |
| 03/29/2006 | CN1247230C Chinese medicine composition for travelling health-protection and preparing method thereof |
| 03/29/2006 | CN1247210C Preparation process of externally used traditional medicine powder resembled placebo |
| 03/29/2006 | CN1247205C Sea cucumber carotenoid lipid fraction products and method of use |
| 03/29/2006 | CN1247192C Assay for identification of compound that promote meianin prodn. and retinoid-like compounds identified by said assay |
| 03/29/2006 | CN1247187C Intravenous injection liquid preparing method of oxygen-enriched broad transfusion |
| 03/29/2006 | CN1247182C Composition of component of skin whitening cosmetics |
| 03/28/2006 | USRE39050 Treating post-menopausal osteoporosis with raloxifene, formerly keoxifene, or raloxifene hydrochloride; new usage |
| 03/28/2006 | US7019147 E.,g.,1-[2-(5-Methoxy-benzoimidazol-1-yl)-quinolin-8-yl]-piperidin-4-ylamine; anticarcinogenic and -tumor agent; KDR tyrosine kinase inhibitors; (KDR=kinase inserrt domain recepter) |
| 03/28/2006 | US7019123 Human bikunin |
| 03/28/2006 | US7019031 By deactivation of the prenylation enzyme through covalent modification; method for screening for cancer drugs by ability to inhibit prenylation |
| 03/28/2006 | US7019029 Topically administering 3,4-dihydroxy,5-(phenylalkyl)-2,5-dihydrofuran-2-one derivatives of given formula; inhibits tyrosinase or tyrosine phosphatase |
| 03/28/2006 | US7019026 Modulators of Protein Tyrosine Phosphatases (PTPases) |
| 03/28/2006 | US7019025 such as N-(4-{[methyl-(2-propynyl)amino]methyl}phenyl)-2-thiophenecarboximidamine; for inhibiting nitrogen oxide synthases and/or monoamine oxidases |
| 03/28/2006 | US7019021 such as 2-(6-bromo-3-dimethylamino-2-methylphenylimino)imidazolidine; stress |
| 03/28/2006 | US7019016 Therapy of sensorineural hearing loss in a mammal by administering NR2B subunit selective N-methyl-D-aspartate (NMDA) NR2B subtype receptor antagonist |
| 03/28/2006 | US7019013 Sulfamidothienopyrimidines |
| 03/28/2006 | US7019007 CCR-3 receptor antagonists (I) |
| 03/28/2006 | US7019006 Compounds useful as anti-inflammatory agents |
| 03/28/2006 | US7019003 Bactericides |
| 03/28/2006 | US7019001 Substituted benzothiazole amide derivatives |
| 03/28/2006 | US7019000 administering nitrogen-sulfur compounds, e.g. 4,4-dithiodimorpholine to inhibit binding of the E6 protein by human papilloma virus; treatment of cervical cancer |
| 03/28/2006 | US7018999 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound. |
| 03/28/2006 | US7018998 substituted 4,5-dihydro-1H-benzo[b][1,4]-diazepin-2-one; amidation of a substituted monoprotected 1,2-diaminobenzene with an ester, deprotecting, cyclization; chronic neurological disorders, psychosis, schizophrenia, Alzheimer's disease |
| 03/28/2006 | US7018997 Tricyclic 6-alkylidene-penems as β-lactamase inhibitors |
| 03/28/2006 | US7018991 A hormonal or antihormonal steroid compound of structure I, amines or amine oxides |
| 03/28/2006 | US7018989 Chemical compounds |
| 03/28/2006 | US7018987 Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof |
| 03/28/2006 | US7018985 Composition and method for inhibiting platelet aggregation |
| 03/28/2006 | US7018981 Gastrointestinal disorders |
| 03/28/2006 | US7018826 Particles for gene therapy |
| 03/28/2006 | US7018810 Chordin-like molecules and uses thereof |
| 03/28/2006 | US7018662 Palliative effects of morinda citrifolia oil and juice |
| 03/28/2006 | US7018620 Delivery of beta-blockers through an inhalation route |
| 03/28/2006 | CA2395186C Procollagen c-proteinase inhibitors |
| 03/28/2006 | CA2386793C New selective retinoid agonists |
| 03/28/2006 | CA2309551C Aminothiazole inhibitors of cyclin dependent kinases |
| 03/28/2006 | CA2291892C Angiostatin fragments and method of use |
| 03/28/2006 | CA2263417C Arylalkanoylpyridazines |
| 03/28/2006 | CA2156121C Method of manufacturing the cycloheptimidazole derivatives |
| 03/28/2006 | CA2147451C 3-indolylpiperidines |
| 03/28/2006 | CA2125104C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/23/2006 | WO2006031556A2 Amidine substituted aryl aniline compounds |
| 03/23/2006 | WO2006031337A2 Combinations of pkc activators and pkc inhibitors for alzheimer’s disease treatment and cognitive enhancement |
| 03/23/2006 | WO2006030984A1 Piperidine compound and process for preparing the same |
| 03/23/2006 | WO2006030980A1 Agent and food for preventing/improving functional digestive disorder |
| 03/23/2006 | WO2006030975A1 Piperidine derivatives and use thereof |
| 03/23/2006 | WO2006030929A1 Carbohydrase inhibitors derived from chestnut and use thereof |
| 03/23/2006 | WO2006030925A1 Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| 03/23/2006 | WO2006030906A1 Nucleoside analogues or salts thereof |
| 03/23/2006 | WO2006030898A1 Aldose reductase inhibitor |
| 03/23/2006 | WO2006030847A1 Novel bicyclic pyrazole derivative |
| 03/23/2006 | WO2006030826A1 Medicinal composition |
| 03/23/2006 | WO2006030805A1 Triazole derivative or salt thereof |
| 03/23/2006 | WO2006030803A1 Purinenucleoside derivative modified in 8-position and medicinal use thereof |
| 03/23/2006 | WO2006030802A1 Method of screening baff suppressor or inhibitor |
| 03/23/2006 | WO2006030753A1 Therapeutic agent for keratoconjunctiva disorder |
| 03/23/2006 | WO2006030693A1 Agents for overcoming hair troubles and method of screening the same |
| 03/23/2006 | WO2006030306A2 Pindolol for treating premenstrual syndrome and premenstrual dysphoric disorder |
| 03/23/2006 | US20060064767 Nonhuman animal reproducing pathogenic conditions of spinal and bulbar muscular atrophy and remedy for spinal and bulbar muscular atrophy |
| 03/23/2006 | US20060063944 Estrone derivatives and process for producing same |
| 03/23/2006 | US20060063942 Mitotic kinesin inhibitors |
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063934 Pyrazole compounds |
| 03/23/2006 | US20060063922 Epidermal differentiation factor |
| 03/23/2006 | US20060063842 Hypogastric and/or perineal pain-relieving agent |
| 03/23/2006 | US20060063838 Activators of peroxisome proliferator-activated receptors |